Clancy E. ACS Report Shows Prostate Cancer on the Rise, Cervical Cancer on the Decline. Renal & Urology News. 2023; 23: NA.

Lindsley CW, Müller CE, Bongarzone S. Diagnostic and therapeutic radiopharmaceuticals. ACS Pharmacol Transl Sci. 2022;19:835–7.

Article  Google Scholar 

Fani M, Maecke HR, Okarvi SM. Radiolabeled peptides: valuable tools for the detection and treatment of cancer. Theranostics. 2012;2:481.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Badipa F, Alirezapour B, Yousefnia H. An overview of radiolabeled RGD peptides for Theranostic Applications. Curr Radiopharm. 2023;16:107–22.

Article  CAS  PubMed  Google Scholar 

Pu F, Xue S, Yang JJ. ProCA1. GRPR: a new imaging agent in cancer detection. Biomark Med. 2016;10:449–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morgat C, MacGrogan G, Brouste V, Vélasco V, Sevenet N, Bonnefoi H, et al. Expression of gastrin-releasing peptide receptor in breast cancer and its association with pathologic, biologic, and clinical parameters: a study of 1,432 primary tumors. J Nucl Med. 2017;58:1401–7.

Article  CAS  PubMed  Google Scholar 

Moreno P, Ramos-Álvarez I, Moody TW, Jensen RT. Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment. Expert Opin Ther Targets. 2016;20:1055–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Aguiar Ferreira C, Fuscaldi LL, Townsend DM, Rubello D, de Barros AL. Radiolabeled bombesin derivatives for preclinical oncological imaging. Biomed Pharmacother. 2017;87:58–72.

Article  Google Scholar 

Li X, Cai H, Wu X, Li L, Wu H, Tian R. New frontiers in molecular imaging using peptide-based radiopharmaceuticals for prostate cancer. Front Chem. 2020;8:583309.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lantry LE, Cappelletti E, Maddalena ME, Fox JS, Feng W, Chen J, et al. 177Lu-AMBA: synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. J Nucl Med. 2006;47:1144–52.

CAS  PubMed  Google Scholar 

Lantry LE, Thomas R, Waser B, Maddalena M, Fox JS, Arunachalam T, et al. Preclinical evaluation of Lu-177-AMBA, a DOTA conjugate that targets GRP and NMB receptor expressing tumors: internalization, in vivo biodistribution, single dose radiotherapy in PC-3 tumor-bearing nude mice and in vitro autoradiography in animal and human tissues. Eur J Nucl Med Mol Imaging. 2004;31:S389–90.

Google Scholar 

Baum R, Prasad V, Mutloka N, Frischknecht M, Maecke H, Reubi J. Molecular imaging of bombesin receptors in various tumors by Ga-68 AMBA PET/CT: first results. J Nucl Med. 2007;48(supplement 2):79P.

Google Scholar 

Zhang-Yin J, Provost C, Cancel-Tassin G, Rusu T, Penent M, Radulescu C, et al. A comparative study of peptide-based imaging agents [68Ga] Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models. Nucl Med Biol. 2020;84:88–95.

Article  PubMed  Google Scholar 

Ho CL, Liu IH, Wu YH, Chen LC, Chen CL, Lee WC et al. Molecular Imaging, Pharmacokinetics, and Dosimetry of 111In-AMBA in human prostate Tumor‐Bearing mice. BioMed Res Int 2011;101497.

Fox J, Maddalena ME, Wedeking P, Chen J, Wang N, Linder K et al. 2007. Comparative biodistributions of 111In, 67Ga and 177Lu-AMBA in PC-3 tumor bearing mice. J Nucl Med. 79P.

Chen J, Feng W, Arunachalam T, Metcalfe E, Nunn A, Linder K. Preparation and in vitro binding of 67Ga-AMBA, comparison to 177Lu-AMBA. Nucl Med; 2007; 48 (supplement 2) 306P.

Bolorinovin F, Mirzaei M, Faghihi R, Joharidaha F, Sina S, Hadad K, et al. Design and construction of a 113Sn/113mIn generator using irradiation of natural indium in a cyclotron accelerator. JONSAT. 2024;45:99–106.

CAS  Google Scholar 

Akbari L, Sina S, Zolghadri S, Moghaddasi A, Hadad K, Yousefnia H. [113mIn]In-PSMA: high potential agent for SPECT imaging of prostate cancer. Radiochim Acta. 2024;112:883–94.

Article  CAS  Google Scholar 

Chu SY. The Lund/LBNL nuclear data search. Available at: http://nucleardata.nuclear.lu.se/nucleardata/toi/index. asp.1999.

Stern HS, Zolle I, McAfee JG. Preparation of technetium (Tc99m)-labeled serum albumin (human). Appl Radiat Isot. 1965;16:283–8.

Article  CAS  Google Scholar 

Rookeman VA, Sun PC, Bruno FP, Dunavant BG. Internal distribution and absorbed dose calculations for radioactive indium liver and lung scanning agents. AJR Am J Roentgenol. 1970;109:735–41.

Potchen EJ, Adatepe M, Welch M, Archer E, Studer R. Indium in 113m for visualizing Body organs: a broad spectrum scanning Agent. JAMA. 1968;205:208–12.

Article  CAS  PubMed  Google Scholar 

O’Mara RE, Subramanian G, McAfee JG, Burger CL. Comparison of 113mIn and other short-lived agents for cerebral scanning. J Nucl Med. 1969;10:18–27.

PubMed  Google Scholar 

Bolourinovin F, Mirzaei M, Faghihi R, Joharidaha F, Sina S, Hadad K, et al. Preparation, Quality control, Biodistribution of [113mIn]In-DOTATATE. JONSAT. 2024;45:29–35.

Google Scholar 

Chen J, Linder KE, Cagnolini A, Metcalfe E, Raju N, Tweedle MF, et al. Synthesis, stabilization and formulation of [177Lu] Lu-AMBA, a systemic radiotherapeutic agent for gastrin releasing peptide receptor positive tumors. Appl Radiat Isot. 2008;66:497–505.

Article  CAS  PubMed  Google Scholar 

Pandey U, Mukherjee A, Jindal A, Gamre N, Korde A, Ram R, et al. Preparation and evaluation of a single vial AMBA kit for 68 Ga labeling with potential for imaging of GRP receptor-positive cancers. J Radioanal Nucl Chem. 2016;307:1115–24.

Article  CAS  Google Scholar